1-Iodooctadecane → 2,6-Diamino-9-(2-O-octadecyl-beta-D-ribofuranosyl)purine

HRID 363242

Reaktionsgleichung

Reaktionsgleichung von HRID 363242
[NH2:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[C@@H:11]2[O:17][C@H:16]([CH2:18][OH:19])[C@@H:14]([OH:15])[C@H:12]2[OH:13])=[C:4]([NH2:20])[N:3]=1.[H-].[Na+].I[CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH3:41]>CN(C=O)C>[NH2:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[C@@H:11]2[O:17][C@H:16]([CH2:18][OH:19])[C@@H:14]([OH:15])[C@H:12]2[O:13][CH2:41][CH2:40][CH2:39][CH2:38][CH2:37][CH2:36][CH2:35][CH2:34][CH2:33][CH2:32][CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26][CH2:25][CH3:24])=[C:4]([NH2:20])[N:3]=1

Komponenten

5

Versuchsvorschrift

2,6-Diamino-9-(β-D-ribofuranosyl) purine (50 g, 180 mmol) and sodium hydride (7 g) in DMF (1 L) were heated to boiling for 2 hr. Iodooctadecane (100 g) was added at 150° C. and the reaction mixture allowed to cool to RT. The reaction mixture was stirred for 11 days at RT. The solvent was evaporated and the residue purified by silica gel chromatography. The product was eluted with 5% MeOH/CH2Cl2. The appropriate fractions were evaporated to yield the product (11 g). 1H NMR (DMSO-d6) δ 0.84 (t, 3, CH2), 1.22 (m, 32, O-CH2 --CH2 --(CH2)16), 1.86 (m, 2, O-CH2CH2), 3.25 (m, 2, O-CH2), 3.93 (d, 1, 4'H), 4.25 (m, 1,3'H), 4.38 (t, 1,2'H), 5.08 (d, 1, 3'-OH), 5.48 (t, 1,5'-OH), 5.75 (s, 2,6-NH2), 5.84 (d, 1, 1'-H), 6.8 (s, 2,2-NH2), and 7.95 (s, 1,8-H).

Aufarbeitung

  1. customThe solvent was evaporated
  2. customthe residue purified by silica gel chromatography
  3. washThe product was eluted with 5% MeOH/CH2Cl2
  4. customThe appropriate fractions were evaporated

Quellen und Nachweise

ORD-Eintrag
ord-78e8ff4bd61e44b2b74f2edc44574ef4
Quelldatensatz
uspto-grants-1999_02
Patentnummer
US05872232

Verknüpfte Notizen

Wird geladen…